Publications by authors named "Dee E Silver"

Claim this Profile
O
Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy.
Alberto J Espay, Fernando L Pagan, Benjamin L Walter, John C Morgan, Lawrence W Elmer, Dee E Silver

Neurol Clin Pract· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physicians' experience with RYTARY (carbidopa and levodopa) extended-release capsules in patients who have Parkinson disease.
Dee E Silver, Richard M Trosch

Neurology· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Treatment with Extended-Release Carbidopa-Levodopa (IPX066) in Early and Advanced Parkinson's Disease: A 9-Month Open-Label Extension Trial.
Cheryl H Waters, Paul Nausieda, Lyudmila Dzyak, Joerg Spiegel, Monika Rudzinska, Dee E Silver

CNS Drugs· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining the efficacy of rasagiline in reducing bradykinesia among Parkinson's disease patients: a review.
Dee E Silver, Philip O Buck

Int J Neurosci· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability and efficacy of switching from oral selegiline to Zydis selegiline in patients with Parkinson's disease.
William G Ondo, Christine Hunter, Stuart H Isaacson, Dee E Silver, R Malcolm Stewart

Parkinsonism Relat Disord· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects.
Kelly E Lyons, Joseph H Friedman, Neal Hermanowicz, Stuart H Isaacson, Robert A Hauser, Dee E Silver

Clin Neuropharmacol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic management of Parkinson's disease in long-term care residents: maintaining functionality to improve quality of life.
Dee E Silver

Director· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early, nondisabling Parkinson's disease: weighing the options for initial therapy.
Dee E Silver

Neurol Clin· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical experience with the novel levodopa formulation entacapone + levodopa + carbidopa (Stalevo).
Dee E Silver

Expert Rev Neurother· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis